Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02132650 · ClinicalTrials.gov registry record · NA

Rehabilitating Corticospinal Control of Walking

A NA study, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
38
Enrollment target

NCT02132650: Completed NA study, sponsored by VA Office of Research and Development.

NCT02132650 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 38 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02132650, a NA study, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
38 participants
Enrollment target

Study Summary

The VHA estimates that over 15,000 Veterans incur a stroke each year. As the population of older Veterans grows, stroke will become an increasingly important problem to the VHA. Recovery of walking function is the most common goal of stroke survivors. The proposed study will test whether training with accurate walking tasks to engage the damaged supraspinal motor pathways is more effective than training with steady state walking. The investigators expect that training accurate tasks will be more effective, thereby improving walking function of Veteran stroke survivors and reducing the burden of care placed on families and on the VHA. Furthermore, this rehabilitation approach can be accomplished at comparable cost to existing rehabilitation approaches, which is important given that the VHA invests $88 million per year toward outpatient care, including physical rehabilitation, in the first six months after stroke. This research also has implications for rehabilitation of other neurologically injured populations, including traumatic brain injury and incomplete spinal cord injury.

Interventions

  • BEHAVIORAL ACC training
  • BEHAVIORAL SS training

Trial Details

FieldValue
Enrollment Target 38 participants
Start Date 2014-06-02
Est. Completion 2019-05-31
Phase NA

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT02132650

The ClinicalTrials.gov registry entry for NCT02132650 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which ACC training is the first listed.

NCT02132650 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02132650 about?

NCT02132650 is a clinical study titled "Rehabilitating Corticospinal Control of Walking". The VHA estimates that over 15,000 Veterans incur a stroke each year. As the population of older Veterans grows, stroke will become an increasingly important problem to the VHA. Recovery of walking function is the most common goal of stroke survivors. The proposed study will test whether training wi...

What is the current status of trial NCT02132650?

This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2014-06-02. Estimated completion is 2019-05-31.

What interventions are being tested in trial NCT02132650?

The interventions under investigation include: ACC training (BEHAVIORAL), SS training (BEHAVIORAL).

Who is sponsoring clinical trial NCT02132650?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.